Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Integrative Biology

Lipoprotein receptor-related protein 1 variants and dietary fatty acids: meta-analysis of European origin and African American studies

Abstract

Objective:

Low-density lipoprotein-related receptor protein 1 (LRP1) is a multi-functional endocytic receptor and signaling molecule that is expressed in adipose and the hypothalamus. Evidence for a role of LRP1 in adiposity is accumulating from animal and in vitro models, but data from human studies are limited. The study objectives were to evaluate (i) relationships between LRP1 genotype and anthropometric traits, and (ii) whether these relationships were modified by dietary fatty acids.

Design and methods:

We conducted race/ethnic-specific meta-analyses using data from 14 studies of US and European whites and 4 of African Americans to evaluate associations of dietary fatty acids and LRP1 genotypes with body mass index (BMI), waist circumference and hip circumference, as well as interactions between dietary fatty acids and LRP1 genotypes. Seven single-nucleotide polymorphisms (SNPs) of LRP1 were evaluated in whites (N up to 42 000) and twelve SNPs in African Americans (N up to 5800).

Results:

After adjustment for age, sex and population substructure if relevant, for each one unit greater intake of percentage of energy from saturated fat (SFA), BMI was 0.104 kg m−2 greater, waist was 0.305 cm larger and hip was 0.168 cm larger (all P<0.0001). Other fatty acids were not associated with outcomes. The association of SFA with outcomes varied by genotype at rs2306692 (genotyped in four studies of whites), where the magnitude of the association of SFA intake with each outcome was greater per additional copy of the T allele: 0.107 kg m−2 greater for BMI (interaction P=0.0001), 0.267 cm for waist (interaction P=0.001) and 0.21 cm for hip (interaction P=0.001). No other significant interactions were observed.

Conclusion:

Dietary SFA and LRP1 genotype may interactively influence anthropometric traits. Further exploration of this, and other diet x genotype interactions, may improve understanding of interindividual variability in the relationships of dietary factors with anthropometric traits.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hossain P, Kawar B, El Nahas M . Obesity and diabetes in the developing world — a growing challenge. N Engl J Med 2007; 356: 213–215.

    Article  CAS  Google Scholar 

  2. Flegal KM, Carroll MD, Ogden CL, Curtin LR . Prevalence and trends in obesity among US adults, 1999–2008. JAMA 2010; 303: 235–241.

    Article  CAS  Google Scholar 

  3. Smith PG, Day NE . The design of case-control studies: the influence of confounding and interaction effects. Int J Epidemiol 1984; 13: 356–365.

    Article  CAS  Google Scholar 

  4. Hein R, Beckmann L, Chang-Claude J . Sample size requirements for indirect association studies of gene-environment interactions (G x E). Genet Epidemiol 2008; 32: 235–245.

    Article  Google Scholar 

  5. Palla L, Higgins JP, Wareham NJ, Sharp SJ . Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol 2010; 171: 1225–1232.

    Article  Google Scholar 

  6. Kraft P, Hunter D . Integrating epidemiology and genetic association: the challenge of gene–environment interaction. Phil Trans R Soc B 2005; 360: 1609–1616.

    Article  CAS  Google Scholar 

  7. Nettleton JA, McKeown NM, Kanoni S, Lemaitre RN, Hivert MF, Ngwa J et al. Interactions of dietary whole-grain intake with fasting glucose– and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care 2010; 33: 2684–2691.

    Article  Google Scholar 

  8. Kanoni S, Nettleton JA, Hivert MF, Ye Z, van Rooij FJ, Shungin D et al. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes 2011; 60: 2407–2416.

    Article  CAS  Google Scholar 

  9. Kilpeläinen TO, Qi L, Brage S, Sharp SJ, Sonestedt E, Demerath E et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med 2011; 8: e1001116.

    Article  Google Scholar 

  10. Bray GA, Paeratakul S, Popkin BM . Dietary fat and obesity: a review of animal, clinical and epidemiological studies. Physiol Behav 2004; 83: 549–555.

    Article  CAS  Google Scholar 

  11. Shikany JM, Vaughan LK, Baskin ML, Cope MB, Hill JO, Allison DB . Is dietary fat ‘fattening’? A comprehensive research synthesis. Crit Rev Food Sci Nutr 2010; 50: 699–715.

    Article  CAS  Google Scholar 

  12. Abete I, Astrup A, Martinez JA, Thorsdottir I, Zulet MA . Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev 2010; 68: 214–231.

    Article  Google Scholar 

  13. Astrup A, Grunwald GK, Melanson EL, Saris WH, Hill JO . The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Disord 2000; 24: 1545–1552.

    Article  CAS  Google Scholar 

  14. Donahoo W, Wyatt HR, Kriehn J, Stuht J, Dong F, Hosokawa P et al. Dietary fat increases energy intake across the range of typical consumption in the United States. Obesity 2008; 16: 64–69.

    Article  CAS  Google Scholar 

  15. Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. New Engl J Med 2009; 360: 859–873.

    Article  CAS  Google Scholar 

  16. de Souza RJ, Bray GA, Carey VJ, Hall KD, LeBoff MS, Loria CM et al. Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. Am J Clin Nutr 2012; 95: 614–625.

    Article  CAS  Google Scholar 

  17. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB . Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 2011; 364: 2392–2404.

    Article  CAS  Google Scholar 

  18. Phillips CM, Goumidi L, Bertrais S, Field MR, Peloso GM, Shen J et al. Dietary saturated fat modulates the association between STAT3 polymorphisms and abdominal obesity in adults. J Nutr 2009; 139: 2011–2017.

    Article  CAS  Google Scholar 

  19. Corella D, Tai ES, Sorli JV, Chew SK, Coltell O, Sotos-Prieto M et al. Association between the promoter polymorphism and body weight in Mediterranean and Asian populations: replication of a gene-saturated fat interaction. Int J Obes (Lond) 2011; 35: 666–675.

    Article  CAS  Google Scholar 

  20. Moleres A, Ochoa MC, Rendo-Urteaga T, Martínez-González MA, Azcona San Julián MC, Martínez JA et al. Dietary fatty acid distribution modifies obesity risk linked to the rs9939609 polymorphism of the fat mass and obesity-associated gene in a Spanish case–control study of children. Br J Nutr 2012; 107: 533–538.

    Article  CAS  Google Scholar 

  21. Hofmann SM, Zhou L, Perez-Tilve D, Greer T, Grant E, Wancata L et al. Adipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice. J Clin Invest 2007; 117: 3271–3282.

    Article  CAS  Google Scholar 

  22. Masson O, Chavey C, Dray C, Meulle A, Daviaud D, Quilliot D et al. LRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue. PLoS One 2009; 4: e7422.

    Article  Google Scholar 

  23. Terrand J, Bruban V, Zhou L, Gong W, El Asmar Z, May P et al. LRP1 controls intracellular cholesterol storage and fatty acid synthesis through modulation of Wnt signaling. J Biol Chem 2009; 284: 381–388.

    Article  CAS  Google Scholar 

  24. Liu Q, Zhang J, Zerbinatti C, Zhan Y, Kolber BJ, Herz J et al. Lipoprotein receptor LRP1 regulates leptin signaling and energy homeostasis in the adult central nervous system. PLoS Biol 2011; 9: e1000575.

    Article  CAS  Google Scholar 

  25. Frazier-Wood AC, Kabagambe EK, Borecki I, Tiwari HK, Ordovas JM, Arnett DK . Preliminary evidence for an association between LRP-1 genotype and body mass index in humans. PloS ONE 2012; 7: e30732.

    Article  CAS  Google Scholar 

  26. Smith CE, Tucker KL, Lee YC, Lai CQ, Parnell LD, Ordovás JM . Low density lipoprotein receptor related protein 1 polymorphism interacts with saturated fatty acids for anthropometric traits in Puerto Ricans. Obesity 2012. e-pub ahead of print 7 August 2012; doi:10.1002/oby.20001.

    Article  CAS  Google Scholar 

  27. Nieters A, Becker N, Linseisen J . Polymorphisms in candidate obesity genes and their interaction with dietary intake of n-6 polyunsaturated fatty acids affect obesity risk in a sub-sample of the EPIC-Heidelberg cohort. Eur J Nutr 2002; 41: 210–221.

    Article  CAS  Google Scholar 

  28. Jourdan C, Kloiber S, Nieters A, Seiler H, Himmerich H, Kohli MA et al. Gene-PUFA interactions and obesity risk. Br J Nutr 2011; 106: 1263–1272.

    Article  CAS  Google Scholar 

  29. Gauthier A, Vassiliou G, Benoist F, McPherson R . Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor gamma. J Biol Chem 2003; 278: 11945–11953.

    Article  CAS  Google Scholar 

  30. House RL, Cassady JP, Eisen EJ, Eling TE, Collins JB, Grissom SF et al. Functional genomic characterization of delipidation elicited by trans-10, cis-12-conjugated linoleic acid (t10c12-CLA) in a polygenic obese line of mice. Physiol Genomics 2005; 21: 351–361.

    Article  CAS  Google Scholar 

  31. Koza RA, Nikonova L, Hogan J, Rim JS, Mendoza T, Faulk C et al. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. Plos Genet 2006; 2: e81.

    Article  Google Scholar 

  32. Perry A, Wang X, Kuo YT . Anthropometric correlates of metabolic syndrome components in a diverse sample of overweight/obese women. Ethn Dis 2008; 18: 163–168.

    PubMed  Google Scholar 

  33. Lissner L, Bjorkelund C, Heitmann BL, Seidell JC, Bengtsson C . Larger hip circumference independently predicts health and longevity in a Swedish female cohort. Obes Res 2001; 9: 644–646.

    Article  CAS  Google Scholar 

  34. Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265.

    Article  CAS  Google Scholar 

  35. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2011.

  36. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937–948.

    Article  CAS  Google Scholar 

  37. Gao Q, Wolfgang MJ, Neschen S, Morino K, Horvath TL, Shulman GI et al. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci USA 2004; 101: 4661–4666.

    Article  CAS  Google Scholar 

  38. Corella D, Arnett DK, Tucker KL, Kabagambe EK, Tsai M, Parnell LD et al. A high intake of saturated fatty acids strengthens the association between the fat mass and obesity-associated gene and BMI. J Nutr 2011; 141: 2219–2225.

    Article  CAS  Google Scholar 

  39. Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 2009; 29: 359–370.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The Atherosclerosis Risk In Communities (ARIC) Study is carried out as a collaborative study supported by National Heart, Lung and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. We the staff and participants of the ARIC study for their important contributions. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. Dr Nettleton is supported by a K01 from the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (5K01DK082729-04). Cardiovascular Health Study (CHS) research was supported by NHLBI contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086; N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HHSN268201200036C and NHLBI grants HL080295, R01-HL085251 HL087652, HL105756 with additional contribution from NINDS. Additional support was provided through AG-023629, AG-15928, AG-20098 and AG-027058 from the NIA. See also http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by National Center of Advancing Translational Technologies CTSI grant UL1TR000124 and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. European Prospective Investigation of Cancer Norfolk (EPIC Norfolk): EPIC-Norfolk is supported by grant funding from the Medical Research Council and Cancer Research United Kingdom with additional support from the Stroke Association, British Heart Foundation, Research Into Ageing and the Academy of Medical Science. The Family Heart Study (FamHS) work was supported by NIH grants R01 HL087700, R01 HL088215 (Michael A. Province) from NHLBI; and R01 DK075681 and R01 DK8925601 from NIDDK (Ingrid B. Borecki). The investigators thank the staff and participants of the FamHS for their important contributions. The Fenland Study is funded by the Wellcome Trust and the Medical Research Council. We are grateful to all the volunteers for their time and help and to the General Practitioners and practice staff for help with recruitment. We thank the Fenland Study co‐ordination team, the Field Epidemiology team and the Fenland Study investigators. Biochemical assays were performed by the National Institute for Health Research, Cambridge Biomedical Research Centre, Core Biochemistry Assay Laboratory and the Cambridge University Hospitals NHS Foundation Trust. The Framingham Offspring Study and Framingham Third Generation Study (FHS) were conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung and Blood Institute’s Framingham Heart Study (Contract No. N01‐HC‐25195) and its contract with Affymetrix, Inc., for genotyping services (Contract No. N02‐HL‐6‐4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA‐II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. Dr Cupples and Mr Ngwa are partially supported by NIH/NIDDK grant R01 DK089256-01. Dr Nicola McKeown is supported by the USDA agreement No. 58-1950-7-707. The GOLDN (Genetics of Lipid Lowering Drugs and Diet Network) study was funded by the National Heart, Lung and Blood Institute Grant No. U01-HL072524, Genetic and Environmental Determinants of Triglycerides. Dr Smith and Dr Ordovás are partially supported by P50 HL105185-01 and contracts 53-K06-5-10 and 58–1950-9–001 from the US Department of Agriculture Research Service. The Health, Aging and Body Composition (Health ABC) study was supported in part by the Intramural Research Program of the NIH, National Institute on Aging contracts N01AG62101, N01AG62103 and N01AG62106. The genome-wide association study was funded by NIA grant R01 AG032098 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. Health Professionals Follow-up Study (HPFS): The HPFS was supported by grants HL71981 and CA055075 from the National Institutes of Health. Dr Lu Qi is a recipient of the American Heart Association Scientist Development Award (0730094N). We thank the participants of the HPFS for their continued cooperation. Invecchiare in Chianti (aging in the Chianti area, InCHIANTI) study investigators thank the Intramural Research Program of the NIH, National Institute on Aging who are responsible for the InCHIANTI samples. Investigators also thank the InCHIANTI participants. The InCHIANTI study baseline (1998–2000) was supported as a ‘targeted project’ (ICS110.1/RF97.71) by the Italian Ministry of Health and in part by the US National Institute on Aging (Contracts: 263 MD 9164 and 263 MD 821336). MESA and the MESA SHARe project are conducted and supported by contracts N01-HC-95159 through N01-HC-95169 and RR-024156 from the National Heart, Lung and Blood Institute (NHLBI). Funding for MESA SHARe genotyping was provided by NHLBI Contract N02‐HL‐6‐4278. MESA Family is conducted and supported in collaboration with MESA investigators; support is provided by grants and contracts R01HL071051, R01HL071205, R01HL071250, R01HL071251, R01HL071252, R01HL071258, R01HL071259. We thank the participants of the MESA study, the Coordinating Center, MESA investigators, and study staff for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. Nurses Health Study (NHS): The NHS was supported by grants HL71981, CA87969 and CA49449 from the National Institutes of Health. Dr Lu Qi is a recipient of the American Heart Association Scientist Development Award (0730094N). We thank the participants of the NHS for their continued cooperation. Rotterdam Study: The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. We thank Pascal Arp, Mila Jhamai, Marijn Verkerk, Lizbeth Herrera and Marjolein Peters for their help in creating the GWAS database, and Karol Estrada and Maksim V. Struchalin for their support in creation and analysis of imputed data. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII) and the Municipality of Rotterdam. We are grateful to the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. Young Finns Study: The Young Finns Study has been financially supported by the Academy of Finland: grants 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi) and 41071 (Skidi), the Social Insurance Institution of Finland, Kuopio, Tampere and Turku University Hospital Medical Funds (grant 9M048 and 9N035 for TeLeht), Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research and Finnish Cultural Foundation, Tampere Tuberculosis Foundation and Emil Aaltonen Foundation (T.L). The authors gratefully acknowledge the statistical analyses provided by Ville Aalto.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J M Ordovás.

Ethics declarations

Competing interests

LD is receipt of travel reimbursement from International Nut and Dried Fruit Inc., and KJM is principal investigator on a Harvard Medical School-funded trial that received a donation of DHA and placebo capsules from Martek Corporation, which had no other role in the trial. The remaining authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on International Journal of Obesity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, C., Ngwa, J., Tanaka, T. et al. Lipoprotein receptor-related protein 1 variants and dietary fatty acids: meta-analysis of European origin and African American studies. Int J Obes 37, 1211–1220 (2013). https://doi.org/10.1038/ijo.2012.215

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2012.215

Keywords

This article is cited by

Search

Quick links